Opioid withdrawal is survivable. Medical supervision makes it manageable.

Opioid medical detox is the supervised process of clearing opioids from the body while managing withdrawal. Unlike alcohol or benzodiazepine detox, opioid withdrawal rarely causes life-threatening complications such as seizures. The risk is different: the severity of physical discomfort is high enough that most people cannot get through it without medical support, and the most common outcome of attempting it without structure is relapse.

That is hard to sit with, and most people searching for an answer are coming from a place of exhaustion.

Body aches, insomnia, diarrhoea, sweating, and extreme restlessness hit their peak between days four and seven. Most people entering detox do not know this. They experience the first two days as manageable and assume the worst is over. It is not. A medical protocol that prepares for days four through seven from the beginning changes that trajectory.

According to NIDA's overview of heroin and opioid use disorder, opioid dependence develops rapidly with regular use, and withdrawal symptoms peak within days of cessation. At Jintara, opioid addiction treatment includes medical detox as an integrated part of the program, not a waiting room before treatment begins. While the nursing team manages the physical withdrawal, the clinical team begins building the therapeutic relationship and introducing the framework the client will use through the rest of their stay.

Opioid withdrawal does not cause the cardiac events or seizures associated with alcohol or benzodiazepine withdrawal. The clinical risk concentrates elsewhere: people leaving acute withdrawal often relapse, then take the same dose their body could no longer handle. That gap between expected and actual tolerance is where overdose deaths occur. Medical oversight closes that gap.

At Jintara, withdrawal monitoring is active through the entire acute phase. Comfort medications reduce the severity of aches, nausea, and insomnia. The Clinical Opiate Withdrawal Scale tells the nursing team whether withdrawal is stabilising or escalating. The presence of a clinical team gives each person a structure to move through rather than a reason to leave.

Every opioid detox protocol at Jintara is designed during a detailed psychiatrist consultation on the day of arrival. The psychiatrist examines the type of opioid used, the amount and duration of use, what previous detoxes looked like, and what the client's preference is between a faster but more intense withdrawal and a slower, more comfortable taper.

There is no single default protocol. A person coming off long-term high-dose heroin requires a different approach from someone stepping down from prescription codeine. A fentanyl user presents specific challenges because of how deeply the drug binds to opioid receptors and how it distributes in body tissue. Someone who has detoxed before and failed on a fast taper may need a slower, more supported approach the second time.

The admissions process includes this psychiatrist meeting on day one. Medical history, current medications, and any co-occurring health conditions are reviewed at the same session. Nothing is assumed from an intake form. The protocol is written after the conversation.

Methadone is a full opioid agonist that reduces or eliminates withdrawal symptoms during the taper period by binding to the same receptors as heroin and prescription opioids. At Jintara, it is used exclusively for opioid detox, not for long-term maintenance. The dose is adjusted daily based on Clinical Opiate Withdrawal Scale scores and clinical observation, then tapered toward zero over the detox period. Faster tapers run five to seven days, more acute but shorter. Slower tapers run two to four weeks, more comfortable but extending the program.

Many clients, particularly those from the United Kingdom, arrive with a negative association with methadone because of its use in community maintenance clinics. Darren Lockie, Founder and CEO of Jintara, explains the reality in a residential detox setting: "We tell them they do not have to take methadone if they do not want to. But when they get here and try without it, they usually come back to me by day three or four. They cannot do it."

Adjunctive comfort medications support the methadone taper throughout the withdrawal period. NIDA's overview of medications used in opioid addiction treatment provides the pharmacological background for methadone's mechanism. See the full list of medication protocols used at Jintara across all substance types.

The Clinical Opiate Withdrawal Scale (COWS) is the standardised tool Jintara nurses use to score opioid withdrawal severity at each observation point. It measures eleven signs: pulse rate, sweating, restlessness, pupil size, bone and joint aches, gastrointestinal upset, tremor, yawning, anxiety, skin sensation changes, and gooseflesh. Each item is scored numerically. A combined score above twelve indicates moderate withdrawal requiring active medication adjustment; above twenty-four indicates severe withdrawal.

COWS scores drive medication decisions in real time. If a score rises between checks, the dose is adjusted that same shift rather than waiting for a scheduled review. This tight loop between observation and response prevents the acute phase from escalating unnecessarily. The clinical validation of the Clinical Opiate Withdrawal Scale confirms its reliability as a real-time decision-making instrument in supervised detox settings.

The structure of the treatment program at Jintara integrates COWS-guided detox with concurrent therapy from day one, rather than treating the two phases as separate.

Opioid withdrawal follows a recognisable progression. The clinical team explains this to every client before it begins, because knowing what is coming is itself a form of support. Days one through three are deceptively manageable. Early signs such as yawning, dilated pupils, restlessness, and mild anxiety lead most people to assume the process will be straightforward. Days four through seven are when the full weight of withdrawal arrives: body aches, insomnia, diarrhoea, sweating, and a psychological state of anhedonia and irritability that can feel as though it will not end.

Fentanyl users often experience a delayed or prolonged withdrawal curve because of how the drug distributes in body tissue. The WHO fact sheet on opioid overdose risk notes that fentanyl is significantly more potent than morphine, which is why a period of reduced tolerance after detox creates heightened overdose risk if relapse occurs. People coming off long-term high-dose heroin typically report more severe peak symptoms than those stepping down from prescription opioids. The clinical team adjusts the protocol based on these differences as withdrawal progresses.

From week two, physical symptoms begin to resolve. Sleep returns incrementally. Energy rebuilds. The dual diagnosis treatment or broader therapy program, which has been running in parallel since day one, becomes easier to engage with.

Therapy at Jintara begins on the day of arrival, running alongside the medical detox rather than waiting for it to resolve. Darren Lockie explains: "Once someone is on a medical detox for opioids or alcohol or anything, they can pretty much do most things in parallel. I do not see any reason why detox should be separate to rehab. They are all one and the same problem."

During the acute withdrawal phase, therapy sessions are lighter. The focus is on psychoeducation, establishing a sense of safety, and beginning to map the client's history. As physical symptoms ease through week two, session depth increases. For clients who started using opioids to manage chronic pain, the clinical team includes an assessment of what non-opioid pain management will look like going forward. Physiotherapy, Thai massage, NSAIDs, and gabapentin are among the options reviewed.

The treatment program at Jintara is built around the individual from the day of arrival, not after detox resolves. The program structure adapts as withdrawal stabilises.